Clinical Trial Update: Phase III Randomized Study of Collagenase in Patients With Residual Stage Dupuytren's Disease [Phase 3]

View source ↗

Summary

Phase III randomized trial of collagenase in patients with residual Dupuytren's Contracture has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dupuytren Contracture

Drugs mentioned

• Collagenase (collagenase)

Snippet

Sponsor: State University of New York | Conditions: Dupuytren's Contracture | Phase 3 | Status: COMPLETED